Abacus Life, Inc. Form 8-K Summary
Business Context and Reporting Period
Company: Abacus Life, Inc. (formerly Abacus Global Management, Inc.)
Reporting Date: December 10, 2024
Business Overview: The Company operates in the life settlement industry, purchasing life insurance policies. This filing reports the entry into a material definitive agreement to secure new debt financing to support operations, policy purchases, working capital, and potential acquisitions.
Key Financial Metrics and Debt Structure
This filing details a new senior secured term loan facility rather than historical operating results. Key terms include:
- Total Facility Size: Up to $150.0 million.
- Initial Drawdown: $100.0 million (Closing Date Facility) fully drawn on December 10, 2024.
- Delayed Draw Option: Up to $50.0 million available subject to conditions.
- Interest Rates: Fixed at 5.25% for SOFR Loans and 4.25% for Base Rate Loans. Rates may step down to 5.00% and 4.00% respectively if specific Consolidated Adjusted EBITDA and Total Leverage Ratio metrics are met.
- Maturity: Six years from the initial funding date.
- Amortization: Quarterly payments of 1% per annum of the aggregate principal, plus additional payments based on Consolidated Adjusted EBITDA.
- Prepayment Penalty: 1.00% premium if prepaid prior to the 12-month anniversary of funding.
Material Changes and Covenants
The execution of the 2024 Credit Agreement represents a significant change in the Company's capital structure. The agreement includes:
- Collateral: Secured on a first lien basis by primarily all assets of the Company and guarantors, including life insurance policies.
- Financial Covenants: Quarterly measurements of a maximum Secured Leverage Ratio, minimum Consolidated Fixed Charge Coverage Ratio, and minimum Asset Coverage Ratio.
- Restrictive Covenants: Limitations on dividends, distributions, additional indebtedness, liens, and asset sales.
- Guaranty: Certain wholly owned and material subsidiaries have issued a guaranty for the obligations.
Outlook, Risks, and Management Commentary
Use of Proceeds: Management intends to use net proceeds for operations, purchasing life settlement policies, working capital, general corporate purposes, funding acquisitions, and refinancing existing indebtedness.
Risks: The filing includes standard forward-looking statement disclaimers. Risks include the Company's ability to meet financial covenants, the impact of interest rates, and general market uncertainties affecting the life settlement industry. Failure to comply with covenants or pay principal/interest could trigger events of default.
Investor Verification Checklist
- Verify the full text of the Credit Agreement (Exhibit 10.1) for specific definitions of "Consolidated Adjusted EBITDA" and leverage ratios.
- Confirm the status of the $50.0 million Delayed Draw Term Loan (DDTL) facility and the conditions required to draw it.
- Review the Company's most recent 10-K or 10-Q to assess current leverage levels against the new maximum Secured Leverage Ratio covenant.
- Monitor future filings for any amendments to the credit agreement or notices of covenant compliance.